THIS COURSE IS SOLD OUT!
Course Directors: Wayne (Nick) T. Nicholson, M.D., Pharm. D.,; Christopher B. Grilli, Pharm.D., R.Ph.
Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, has reached the translational stage for various specialties in medicine. This conference provides the background, resources and practical application examples to implement pharmacogenomics and make a difference in patients' lives.
Mayo Clinic experts, with experience leading the implementation of pharmacogenomics, will provide practical guidance on a range of topics, background and research involving pharmacogenomics, when to order testing, drug/gene selection, informatics, and case study working sessions.
Registration Fee: $395.00
Program Schedule (PDF)
Lodging and Accommodations
Center for Individualized Medicine PGx Testing
PGx Testing Available
**The order date has expired for testing results to arrive prior to the conference. However, the discounted rate is available until December 7th**
This conference is providing the opportunity to have Pharmacogenomic testing at a discounted fee, to aid in the educational experience. The OneOme RightMed® pharmacogenomic test is a one-time offer of a single test kit at a discounted fee of $120 and needs to be ordered through a medical care provider. There is no obligation to purchase any OneOme service(s) now or in the future.
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibiting at this course, please email Nichole Nicholas.
This course is designed for pharmacists, nurses, physicians, nurse practitioners, physician assistants, genetic counselors and any other members of the patient care team.
Upon conclusion of this program, participants should be able to:
- Illustrate how guidelines can be used by clinicians to make specific prescribing decisions for patient care when genetic information is available
- Identify key principles for implementation of pharmacogenomics into clinical practice
- Outline PGx recommendations based on available evidence in various disease states including cardiac disease, cancer, psychiatry, pain and more.
- Describe an example of preemptive testing for inpatients and outpatients
- Identify PGx tests available for use in clinical practice
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Center for Individualized Medicine Education